Purpose: To evaluate the role of botulinum toxin A (BTA) in treating p
atients with diminished visual acuity secondary to acquired nystagmus
and oscillopsia.Methods: Twelve patients with acquired nystagmus causi
ng oscillopsia and reduced vision were treated with injection of BTA.
Botulinum toxin A was injected directly into the horizontal recti in t
hree patients, and in nine patients retrobulbar BTA was administered.
Injections were given at 3- to 4-month intervals and repeated as long
as patients noted improvement in their quality of life. Results: Impro
vement in visual function varied, and not all patients benefited from
the procedure. However, 8 of 12 patients demonstrated a measurable imp
rovement in visual acuity. Transient ptosis was the most common side e
ffect. Conclusion: Retrobulbar BTA provides a simple and safe alternat
ive in managing a condition for which alternative treatments are typic
ally unsatisfactory.